1134203-81-8

Basic information

• Product Name: N-((5-bromopyridin-2-yl)methyl)-2-chloro-N-isobutylbenzenesulfonamide
• Synonyms: N-((5-bromopyridin-2-yl)methyl)-2-chloro-N-isobutylbenzenesulfonamide
• CAS NO: 1134203-81-8
• Molecular Weight: 417.754
• Mol File: 1134203-81-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-((5-bromopyridin-2-yl)methyl)-2-chloro-N-isobutylbenzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-((5-bromopyridin-2-yl)methyl)-2-chloro-N-isobutylbenzenesulfonamide(1134203-81-8)
• EPA Substance Registry System: N-((5-bromopyridin-2-yl)methyl)-2-chloro-N-isobutylbenzenesulfonamide(1134203-81-8)

Safety Data

• Hazardous Substances Data: 1134203-81-8(Hazardous Substances Data)

Upstream product

• 88139-91-7 (5-bromopyridin-2-yl)methanol 
• 1095871-85-4 2-chloro-N-isobutyl-benzenesulfonamide 

Relevant articles and documents

SMALL MOLECULE LXR INVERSE AGONISTS

The invention is directed to small molecule inverse agonists of the liver X receptor, LXR. These compounds have potential use in the treatment of the following disorders: non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, obesity, insulin resistance, and metabolic syndrome. The invention is directed, in various embodiments, to small molecule inverse agonists of the liver X receptor, LXR. Administration of an effective amount of a compound of the invention, such as compound of formula (I), can be used to suppress hepatic lipogenesis, inflammation, or hepatic lipid accumulation in a mammal.